The association between inflammation and glucose levels in hospitalised patients with type 2 diabetes
- PMID: 40698572
- DOI: 10.1111/dom.16640
The association between inflammation and glucose levels in hospitalised patients with type 2 diabetes
Abstract
Aims: Stress-induced hyperglycaemia can exacerbate existing diabetes. However, the relationship between inpatient inflammation and glucose levels is not well understood.
Materials and methods: This post hoc analysis utilised data from the DIATEC trial (N = 166), a two-arm randomised controlled trial comparing glucose management with real-time continuous glucose monitoring (CGM) or point-of-care glucose testing in non-intensive care unit (non-ICU) patients with type 2 diabetes treated with a basal-bolus insulin regimen. Inflammation was measured as C-reactive protein (CRP) levels daily, and its association with daily glycaemic outcomes and insulin doses was assessed.
Results: For every 100 mg/dL increase in CRP, time in range 3.9-10.0 mmol/L (70-180 mg/dL) decreased by 3.6%-points (95% CI: 1.2-6.1, p = 0.004). An interaction was found between high CRP (>75.0 mg/dL) and high HbA1c (>51.0 mmol/mol or 6.8%), associated with an 8.9%-point reduction in TIR (95% CI: 3.8-14.1). Time above range >10.0 mmol/L (>180 mg/dL) increased by 3.3%-points (95% CI: 0.8-5.8, p = 0.009), and mean glucose increased by 0.2 mmol/L (95% CI: 0.02-0.4) (4.0 mg/dL, 95% CI: 0.4-7.0) for every 100 mg/dL increase in CRP. No significant associations were found between CRP and time below range <3.9 mmol/L (<70 mg/dL), glycaemic variability, hypoglycaemic events, or total daily insulin dose (all p > 0.05).
Conclusions: Elevated CRP levels only modestly increased glucose levels. This suggests that inflammation during hospitalisation has a limited effect on glucose levels in non-ICU patients with type 2 diabetes.
Keywords: clinical trial; continuous glucose monitoring (CGM); insulin resistance; type 2 diabetes.
© 2025 John Wiley & Sons Ltd.
References
REFERENCES
-
- Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978‐982.
-
- Olsen MT, Dungu AM, Klarskov CK, Jensen AK, Lindegaard B, Kristensen PL. Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community‐acquired pneumonia. BMC Pulm Med. 2022;22(1):83.
-
- Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284‐289.
-
- Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013;17:305.
-
- Mifsud S, Schembri EL, Gruppetta M. Stress‐induced hyperglycaemia. Br J Hosp Med. 2018;79(11):634‐639.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
